Beneficial Outcomes of a Steroid-Free Regimen With Thymoglobulin Induction in Pancreas-Kidney Transplantation

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1551-1554

  Tanchanco, R ^a   Krishnamurthi, V ^a   Winans, C ^a   Wee, A ^a   Duclos, A ^a   Nurko, S ^a   Fatica, R ^a   Lard, M ^a   Poggio, E D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BK VIRUS; CYTOMEGALOVIRUS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY PANCREAS TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; VIREMIA;

ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45449104639     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.081     Document Type: Article

References (13)

1. Pascual J., Zamora J., Quereda Z., et al., Spanish Group for Evidence Based Nephrology. Steroid withdrawal or avoidance in kidney or kidney pancreas transplantation: a systematic review. In World Transplant Congress 2006 supplement. Am J Transplantation (Abstract 332) (2006)
2. Racusen L.C., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713
3. Drachenberg C.B., et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 63 (1997) 1579
4. Kaufman D.B., et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction-long-term results. Am J Transplant 6 (2006) 331
5. Axelrod D., et al. Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients. Am J Transplant 5 (2005) 1423
6. Gruessner R.W., et al. A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation-a preliminary report with 6-month follow-up. Transplant Proc 33 (2001) 1663
7. Cantarovich D., et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 5 (2005) 1332
8. Freise C.E., et al. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc 36 (2004) 1067
9. Fridell J.A., et al. Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation 82 (2006) 389
10. Gruessner R.W., et al. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation 79 (2005) 1184
11. Jordan M.L., et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation 69 (2000) 265
12. Knight R.J., Kerman R.H., McKissick E., et al. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Transplant Proc 37 (2005) 3538
13. Vincenti F., and Stock P. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplant Proc 35 3 suppl (2003) 183S